FDA Inspection 585985 — Deitz, M.D., Robert

Deitz, M.D., Robert — FEI 3007502863

The FDA completed an inspection of Deitz, M.D., Robert on May 28, 2009 in San Francisco, CA. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 8 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI)
End Date
May 28, 2009
Fiscal Year
2009
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Francisco, CA (United States)

Additional Details

Clinical Investigator (CI)

Citations

IDCFRDescription
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence
722721 CFR 50.27(a)Consent form not approved/signed/dated
752021 CFR 312.64(b)Safety reports
752621 CFR 312.62(a)Accountability records
753021 CFR 312.62(b)Case history records- inadequate or inadequate
753121 CFR 312.62(c)Record retention
756021 CFR 312.60FD-1572, protocol compliance
756221 CFR 312.60Informed consent